Promoter complex in the central part of the mouse mammary tumor virus lone terminal repeat

Journal of Virology

Volumn 81, Issue 22, 2007, Pages 12572-12581

  Rouault, Francoise ^a,b   Asl, Shiva Badihi Nejad ^b,c   Rungaldier, Stefanie ^b,c   Fuchs, Eva ^b,c   Salmons, Brian ^a   Günzburg, Walter H ^b,c  

^a Austrianova   (Austria)

^b INSTITUTE FOR MICROELECTRONICS   (Austria)

^c Research Institute for Virology and Biomedicine   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

HISTIDINE; LUCIFERASE; TRANSCRIPTION FACTOR; VIRUS PROTEIN;

ARTICLE; COMPLEX FORMATION; GENE ACTIVATION; GENE CLUSTER; GENE CONTROL; GENE EXPRESSION; INTRON; LONG TERMINAL REPEAT; MOLECULAR WEIGHT; MOUSE MAMMARY TUMOR ONCOVIRUS; NONHUMAN; NUCLEOTIDE SEQUENCE; OPEN READING FRAME; PRIORITY JOURNAL; PROMOTER REGION; REGULATORY SEQUENCE; RETROVIRUS; VIRUS GENOME;

AMINO ACID SEQUENCE; ANIMALS; BASE SEQUENCE; GENE EXPRESSION REGULATION, VIRAL; GENES, REPORTER; LUCIFERASES; MAMMARY TUMOR VIRUS, MOUSE; MICE; MOLECULAR SEQUENCE DATA; OPEN READING FRAMES; PROMOTER REGIONS (GENETICS); PROTEIN BIOSYNTHESIS; RNA SPLICE SITES; TERMINAL REPEAT SEQUENCES; TRANSCRIPTION INITIATION SITE; TRANSCRIPTION, GENETIC; VIRAL PROTEINS;

MOUSE MAMMARY TUMOR VIRUS; MURINAE;

EID: 36049044570     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.00351-07     Document Type: Article

References (41)

1. Ball, J. K., H. Diggelmann, G. A. Dekaban, G. F. Grossi, R. Semmler, P. A. Waight, and R. F. Fletcher. 1988. Alterations in the U3 region of the long terminal repeat of an infectious thymotropic type B retrovirus. J. Virol. 62:2985-2993.
2. Reference deleted.
3. Reference deleted.
4. Bramblett, D., C. L. Hsu, M. Lozano, K. Earnest, C. Fabritius, and J. Dudley. 1995. A redundant nuclear protein binding site contributes to negative regulation of the mouse mammary tumor virus long terminal repeat. J. Virol. 69:7868-7876.
5. Brasier, A. R., J. E. Tate, and J. F. Habener. 1989. Optimized use of the firefly luciferase assay as a reporter gene in mammalian cell lines. BioTechniques 7:1116-1122.
6. Buetti, E., and H. Diggelmann. 1983. Glucocorticoid regulation of mouse mammary tumor virus: identification of a short essential DNA region. EMBO J. 2:1423-1429.
7. Buetti, E., and B. Kühnel. 1986. Distinct sequence elements involved in the glucocorticoid regulation of the mouse mammary tumor virus promoter identified by linker scanning mutagenesis. J. Mol. Biol. 190:379-389.
8. Cato, A. C., P. Skroch, J. Weinmann, P. Butkeraitis, and H. Ponta. 1988. DNA sequences outside the receptor-binding sites differently modulate the responsiveness of the mouse mammary tumour virus promoter to various steroid hormones. EMBO J. 7:1403-1410.
9. Crandell, R. A., C. G. Fabricant, and W. A. Nelson-Rees. 1973. Development, characterization, and viral susceptibility of a feline (Felis catus) renal cell line (CRFK). In Vitro 9:176-185.
10. Fasel, N., K. Pearson, E. Buetti, and H. Diggelmann. 1982. The region of mouse mammary tumor virus DNA containing the long terminal repeat includes a long coding sequence and signals for hormonally regulated transcription. EMBO J. 1:3-7.
11. Giffin, W., H. Torrance, H. Saffran, H. L. MacLeod, and R. J. Hache. 1994. Repression of mouse mammary tumor virus transcription by a transcription factor complex. Binding of individual components to separated DNA strands. J. Biol. Chem. 269:1449-1459.
12. Gouilleux, F., B. Sola, B. Couette, and H. Richard-Foy. 1991. Cooperation between structural elements in hormono-regulated transcription from the mouse mammary tumor virus promoter. Nucleic Acids Res. 19:1563-1569.
13. Groner, B., N. E. Hynes, U. Rahmsdorf, and H. Ponta. 1983. Transcription initiation of transfected mouse mammary tumor virus LTR DNA is regulated by glucocorticoid hormones. Nucleic Acids Res. 11:4713-4725.
14. Günzburg, W. H., F. Heinemann, S. Wintersperger, T. Miethke, H. Wagner, V. Erfle, and B. Salmons. 1993. Endogenous superantigen expression controlled by a novel promoter in the MMTV long terminal repeat. Nature 364:154-158.
15. Günzburg, W. H., R. M. Saller, and B. Salmons. Retroviral vectors directed to predefined cell types for gene therapy. Biologicals 23:5-12.
16. Hsu, C. L., C. Fabritius, and J. Dudley. 1988. Mouse mammary tumor virus proviruses in T-cell lymphomas lack a negative regulatory element in the long terminal repeat. J. Virol. 62:4644-4652.
17. Hynes, N., A. J. Van Ooyen, N. Kennedy, P. Herrlich, H. Ponta, H., and B. Groner. 1983. Subfragments of the large terminal repeat cause glucocorticoid-responsive expression of mouse mammary tumor virus and of an adjacent gene. Proc. Natl. Acad. Sci. USA 80:3637-3641.
18. Indik, S., W. H. Günzburg, B. Salmons, and F. Rouault. 2005. Mouse mammary tumor virus infects human cells. Cancer Res. 65:1-9.
19. Jeanson, L., and J. F. Mouscadet. 2002. Ku represses the HIV-1 transcription: identification of a putative Ku binding site homologous to the mouse mammary tumor virus NRE1 sequence in the HIV-1 long terminal repeat. J. Biol. Chem. 277:4918-4924.
20. Kang, C. J., and D. O. Peterson. 1999. Identification of a protein that recognizes a distal negative regulatory element within the mouse mammary tumor virus long terminal repeat. Virology 264:211-219.
21. Kusk, P., K. E. Carlson, B. S. Warren, and G. L. Hager. 1995. Role of the TATA box in transcription of the mouse mammary tumor virus long terminal repeat. Mol. Endocrinol. 9:1180-1192.
22. Lee, J. W., P. G. Moffitt, K. L. Morley, and D. O. Peterson. 1991. Multipartite structure of a negative regulatory element associated with a steroid hormone-inducible promoter. J. Biol. Chem. 266:24101-24108.
23. Lefebvre, P., D. S. Berard, M. G. Cordingley, and G. L. Hager. 1991. Two regions of the mouse mammary tumor virus long terminal repeat regulate the activity of its promoter in mammary cell lines. Mol. Cell. Biol. 11:2529-2537.
24. Liu, J., D. Bramblett, Q. Zhu, M. Lozano, R. Kobayashi, S. R. Ross, and J. P. Dudley. 1997. The matrix attachment region-binding protein SATB1 participates in negative regulation of tissue-specific gene expression. Mol. Cell. Biol. 17:5275-5287.
25. Maxwell, I. H., G. S. Harrison, W. M. Wood, and F. Maxwell. 1989. A DNA cassette containing a trimerized SV40 polyadenylation signal which efficiently blocks spurious plasmid-initiated transcription. BioTechniques 7:276-280.
26. Michalides, R., E. Wagenaar, and P. Weijers. 1985. Rearrangements in the long terminal repeat of extra mouse mammary tumor proviruses in T-cell leukemias of mouse strain GR result in a novel enhancer-like structure. Mol. Cell. Biol. 5:823-830.
27. Mink, S., H. Ponta, and A. Cato. 1990. The long terminal repeat region of the mouse mammary tumour virus contains multiple regulatory elements. Nucleic Acids Res. 18:2017-2024.
28. Mustafa, F., S. Bhadra, D. Johnston, M. Lozano, and J. P. Dudley. 2003. The type B leukemogenic virus truncated superantigen is dispensable for T-cell lymphomagenesis. J. Virol. 77:3866-3870.
29. Reuss, F. U., and J. M. Coffin. 2000. The mouse mammary tumor virus transcription enhancers for hematopoietic progenitor and mammary gland cells share functional elements. J. Virol. 74:8183-8187.
30. Ringold, G. M., K. R. Yamamoto, J. M. Bishop, and H. E. Varmus. 1977. Glucocorticoid-stimulated accumulation of mouse mammary tumor virus RNA: increased rate of synthesis of viral RNA. Proc. Natl. Acad. Sci. USA 74:2879-2883.
31. Rungaldier, S., S. B. N. Asl, W. H. Günzburg, B. Salmons, and F. Rouault. 2005. Abundant authentic MMTV-Env production from a provirus lacking the major LTR promoter. Virology 342:201-214.
32. Salmons, B., B. Groner, C. M. Calberg-Bacq, and H. Ponta. 1985. Production of mouse mammary tumour virus upon transfection of a recombinant proviral DNA into cultured cells. Virology 144:101-114.
33. Salmons, B., T. Miethke, S. Wintersperger, M. Müller, G. Brem, and W. H. Günzburg. 2000. Superantigen expression is driven by both MMTV LTR promoters in transgenic mice. J. Virol. 74:2900-2902.
34. Tanaka, H., Y. Dong, Q. Li, S. Okret, and J. A. Gustafsson. 1991. Identification and characterization of a cis-acting element that interferes with glucocorticoid-inducible activation of the mouse mammary tumor virus promoter. Proc. Natl. Acad. Sci. USA 88:5393-5397.
35. Theunissen, H. J., M. Paardekooper, L. J. Maduro, R. J. Michalides, and R. Nusse. 1989. Phorbol ester-inducible T-cell-specific expression of variant mouse mammary tumor virus long terminal repeats. J. Virol. 63:3466-3471.
36. Wintersperger, S., B. Salmons, T. Miethke, V. Erfle, H. Wagner, and W. H. Günzburg. 1995. Negative acting factor and superantigen are separable activities encoded by the mouse mammary tumor virus long terminal repeat. Proc. Natl. Acad. Sci. USA 92:2745-2749.
37. Xu, L., T. J. Wrona, and J. P. Dudley. 1997. Strain-specific expression of spliced MMTV RNAs containing the superantigen gene. Virology 236:54-65.
38. Yanagawa, S., A. Murakami, and H. Tanaka. 1990. Extra mouse mammary tumor proviruses in DBA/2 mouse lymphomas acquire a selective advantage in lymphocytes by alteration in the U3 region of the long terminal repeat. J. Virol. 64:2474-2483.
39. Yanagawa, S., K. Kakimi, H. Tanaka, A. Murakami, Y. Nakagawa, Y. Kubo, Y. Yamada, H. Hiai, K. Kuribayashi, T. Masuda, and A. Ishimoto. 1993. Mouse mammary tumor virus with rearranged long terminal repeats causes murine lymphomas. J. Virol. 67:112-118.
40. Zhu, Q., K. Gregg, M. Lozano, J. Liu, and J. P. Dudley. 2000. CDP is a repressor of mouse mammary tumor virus expression in the mammary gland. J. Virol. 74:6348-6357.
41. Zhu, Q., and J. P. Dudley. 2002. CDP binding to multiple sites in the mouse mammary tumor virus long terminal repeat suppresses basal and glucocorticoid-induced transcription. J. Virol. 76:2168-2179.